| Zhang, Bo |
NCT06263348: A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes |
|
|
| Recruiting | 4 | 2000 | RoW | Dorzagliatin tablets | Hua Medicine Limited, Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd. | Type2diabetes | 04/26 | 04/26 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
| Recruiting | 1/2 | 300 | RoW | OH2 injection, with or without irinotecan or HX008 | Binhui Biopharmaceutical Co., Ltd. | Solid Tumor, Gastrointestinal Cancer | 08/25 | 08/25 | | |
NCT04762602: A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations |
|
|
| Active, not recruiting | 1 | 90 | Europe, US | HMPL-306 | Hutchmed | Isocitrate Dehydrogenase Gene Mutation | 03/25 | 09/25 | | |
NCT04936178: A Study of NB003 in Patients With Advanced Malignancies |
|
|
| Recruiting | 1 | 258 | Europe, US, RoW | NB003 tablets | Ningbo Newbay Technology Development Co., Ltd | Advanced Solid Tumor | 07/25 | 12/25 | | |
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction |
|
|
| Recruiting | N/A | 250 | RoW | Dexmedetomidine (DEX), Placebo (Saline) | Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd. | ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection | 12/24 | 12/25 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Li, Hao |
NCT05079022: ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas |
|
|
| Not yet recruiting | 1/2 | 50 | RoW | Furmonertinib, AST2818, AST5902 | Peking University People's Hospital, Beijing CSCO-Allist Cancer Research Foundation, Shanghai Allist Pharmaceutical Technology Co., Ltd., Guangzhou Burning Rock Medical Examination Institute Co., Ltd. | Adenocarcinoma of Lung | 03/23 | 09/24 | | |
| Chan, Jianjun |
| No trials found |
| Chen, Liangfeng |
| No trials found |
| Xia, Jumei |
| No trials found |
